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Abstract
Background: Genetic variants in the FTO (fat mass and obesity associated) gene have been
associated with an increased risk of obesity. However, the function of its protein product has not
been experimentally studied and previously reported sequence similarity analyses suggested the
absence of homologs in existing protein databases. Here, we present the first detailed
computational analysis of the sequence and predicted structure of the protein encoded by FTO.
Results: We performed a sequence similarity search using the human FTO protein as query and
then generated a profile using the multiple sequence alignment of the homologous sequences.
Profile-to-sequence and profile-to-profile based comparisons identified remote homologs of the
non-heme dioxygenase family.
Conclusion: Our analysis suggests that human FTO is a member of the non-heme dioxygenase
(Fe(II)- and 2-oxoglutarate-dependent dioxygenases) superfamily. Amino acid conservation
patterns support this hypothesis and indicate that both 2-oxoglutarate and iron should be
important for FTO function. This computational prediction of the function of FTO should suggest
further steps for its experimental characterization and help to formulate hypothesis about the
mechanisms by which it relates to obesity in humans.
Background
Two recent reports [1,2] characterized the strong associa-
tion of a number of single nucleotide polymorphisms
(SNPs) in intron 1 of the human FTO  gene with an
increased risk of obesity, characterized by an increase in
body max index due to fat mass rather than lean mass that
is seen in children as early as age seven [2].
However, the mechanisms by which this genetic variabil-
ity relates to obesity remain obscure. These publications
indicate that the function of FTO is unknown [2] and that
its protein has no identified structural domain or link to
other proteins that could be used to predict its function
[1]. Knowledge of the function of FTO is crucial to guide
the search for a mechanism relating this gene to obesity.
Here we report evidence obtained by computational anal-
ysis indicating that the protein coded by FTO is a member
of the non-heme dioxygenase (Fe(II)- and 2-oxoglutarate-
dependent dioxygenases) superfamily.
Results and Discussion
In the course of the computational characterization of the
FTO family (see Methods) we identified sequences
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homologous to human FTO in different eukaryote groups
including vertebrates (from fish to mammals), green algae
(Ostreococcus) and diatoms (Phaeodactylum and Thalassio-
sira) (see Figure 1 and Table 1).
Using sequence profiles of the N-terminal conserved
region of the FTO family (corresponding to the human
FTO sequence amino acid positions 57–324) members of
the non-heme dioxygenase family were identified. Addi-
tionally, the secondary structure predictions of the FTO
family showed high similarity with the known structures
of AlkB, a member of the non-heme dioxygenase family
[3-5]. We were not able to find significant homology in
the C-terminal of the FTO family to other genes.
To investigate if fold recognition analysis would generate
supporting results, we submitted the FTO N-terminal
region as a query to an independent fold assignment sys-
tem based on profile-profile comparisons (see Methods).
The profiles generated for the human and E. coli AlkB pro-
teins (PDB entries 2iuw and 2fdi) matched the FTO N-ter-
minal region with an E-Value of 3.2 × 10-21 and 3.1 × 10-
12, respectively (estimated error rate < 3%) despite their
low level of sequence identity to the human FTO protein
(approximately 17%). The next match corresponded to
the hypothetical protein TM0957 from Thermotoga mar-
itima, however it was considered unreliable given its short
length (28 amino acids) and high E-value (0.02).
Given the E-values of the HMMer searches, the reliability
of secondary structure predictions, and the fold assign-
ment results, we are confident that the proteins of the FTO
family (including the protein coded by the FTO human
gene) are members of the non-heme dioxygenase super-
family.
Proteins of this superfamily catalyze different oxidative
reactions on multiple substrates producing varied biolog-
ical effects [6] and are characterized by a number of con-
served amino acids involved in the binding of iron and 2-
oxoglutarate (as a cofactor and co-substrate, respectively).
We found these amino acids in human FTO and in its
homologs (see Figure 1 and Table 1), suggesting that 2-
oxoglutarate and iron are essential for the normal func-
tion of the FTO protein.
The FTO family is not a unique case as other families of
the non-heme dioxygenase superfamily are also very
divergent and their detection required non-trivial compu-
tational analysis [3]. Due to the divergence of the FTO
family from already known non-heme dioxygenases, we
were unable to predict the target of the family's catalytic
action.
The ubiquitous expression of FTO throughout many
human tissues [1] indicates that it has an important func-
tion. The phylogenetic distribution of FTO homologs
(consistently present in organisms from fish to mammals)
suggests that this gene appeared during the evolution of
vertebrates. Intriguingly, FTO homologs can be found in
green algae Ostreococcus and diatoms, whereas they are
apparently absent in insects, worms and fungi (see Figure
1 and Table 1). The most parsimonious explanation of
this fact is the existence of independent events of horizon-
tal gene transfer from vertebrates to protists. Horizontal
gene transfer has previously been related to the evolution
of several eukaryotic regulatory systems that function in
development, differentiation and apoptosis [7]. Con-
cisely, horizontal transfer of FTO indicates that the FTO
protein has a function that confers a selective advantage
but that it is not indispensable, which agrees with a possi-
ble regulatory role.
For comparison, the hypoxia-inducible factor (HIF), a
known member of the non-heme dioxygenase family,
also has a wide phylogenetic distribution (from worms to
mammals) and is ubiquitously expressed in all human tis-
sues. HIF acts as a sensor of oxygen level and affects the
expression of over one hundred genes [8]. This molecule
performs its activity by shuttling between the cytoplasm
in normoxic conditions and the nucleus in hypoxic condi-
tions [9].
To investigate if FTO could be acting in a similar manner,
we studied its sequence using an algorithm for prediction
of protein cellular localization (WolfPSORT; [10]). The
results suggested with similar scores a cytoplasmic and a
nuclear-cytoplasmic localization for this protein. This is
consistent with human FTO's possible function as a met-
abolic sensor and nuclear effector.
The FTO human gene product has a predicted molecular
mass of 50 KDa. With that mass it would need a Nuclear
Localization Signal (NLS) [11] in order to act in the
nucleus. Analysis of FTO's sequence using an algorithm
that includes the prediction of NLS (PSORTII; [10]) sug-
gested a 17 amino acid long bipartite NLS from positions
2 to 18 (Figure 2A) noted previously [12] but not experi-
mentally verified. Further analysis of the family indicated
that this region stands as a K/R rich region in comparison
to the rest of the sequence, and that it is located in an N-
terminal extension that is conserved in close human
homologs from fish to mammals but not in the other FTO
homologues we found in algae or diatomea.
In light of these computational results we hypothesize
that FTO is a sensor of the cell's metabolic state and when
dysfunctional can result in an obese phenotype. We iden-
tify the N-terminal of human FTO as having a high likeli-BMC Biochemistry 2007, 8:23 http://www.biomedcentral.com/1471-2091/8/23
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Computational analysis of the FTO family Figure 1
Computational analysis of the FTO family. Top. Multiple sequence alignment of the FTO family with known members of 
the non-heme dioxygenase superfamily. Red triangles above the alignment mark the conserved residues involved in iron and 2-
oxoglutarate (2OG) binding with numbers indicating their position in AlkB. The numbers within the red box represent 
sequence insertions that we did not include in the alignment. X-Ray determined secondary structure of AlkB (PDB code 2fdi) 
[5] and hABH3 (PDB code 2iuw) [4] are shown below their sequences. PHD secondary structure prediction [26] for the FTO 
family is included below the human FTO sequence. The alignment was produced using a combination of T-COFFEE [17] and 
profile-to-profile alignment [24], using the structure-based superposition hABH3/AlkB alignment [28] as reference. Finally, the 
alignment was slightly refined manually. It was represented with the program Belvu [18] with a coloring scheme indicating aver-
age BLOSUM62 score (correlated to amino acid conservation) in each alignment column: dark red (greater than 3), violet 
(between 3 and 1) and light yellow (between 1 and 0.3). The sequences are named with their SwissProt or SpTrembl identifi-
ers. Species abbreviations: Azovi, Azotobacter vinelandii; Caucr, Caulobacter crescentus; Comte, Comamonas testosteroni; Ecoli, 
Escherichia coli; Human, Homo sapiens; Jansp, Jannaschia sp.; Metfl, Methylobacillus flagellatus; Mouse, Mus musculus; Ocesp, 
Oceanospirillum sp.; Oryla, Oryzia latipes; Ostlu, Ostreococcus lucimarinus; Ostta, Ostreococcus tauri; Shewo, Shewanella woodyi; 
Synsp, Synechococcus sp.; Thaps, Thalassiosira pseudonana; Xenla, Xenopus laevis. Additional details about some lanes and FTO 
close homologous sequences can be found in Table 1. Complementary information, sequences, and alignments are accessible at 
[29]. Bottom. Structure of AlkB (PDB code 2fdi) indicating with sticks the invariant side chains in non-heme dioxygenases 
which are also conserved in the FTO family.
LRRFAFN.AAEQLIRDINDVASQSPFRQMVTP.GGYTMSV...AMTNCGHLGWTTHRQGYLYSPIDPQTNKPWPAMPQSFHNLCQRAATAAGYPDFQPDACLINRYAP.............. ALKB_ECOLI  22
Sec_2fdi
LRGFASE.QDQQLLHDLQTVLAQAPWRHMQTP.GGLAMSV...AMCNCGRLGWVSDRAGYRYTTHDPLSGKVWPAMPPSFAALAQSAAATVGFARFVPDACLINRYQT.............. Q1H1R8_Metfl  50
LRGFATA.EEQRWVAEARALQTRAAFRTMQVP.GGKSMSV...AITNAGGWGWISDLQGYRYSAADPQTGKPWPAIPAFLGEQAARAAALAGYPGFAPDACLINCYQP.............. A0HF04_Comte  23
WPGLLDISAQRALVEAVLAGAEQAPFSNYRTA.YGKPMSV...AMTALGSLGWTSDARGYRYVDRHPETGRPWPDMPPALLDLWTVLGDP....ETPPDSCLVNLYRD.............. O05725_Caucr  29
HPEHLDGPDQAELVEQVRRVVRSAPLYRPETR.TGRKMSV...RMTSAGTYGWISDRRGYRYDRCHPDGQ.DWPPIPPMALEIWRAVSGV....AQDPQSCLINYYDA.............. Q28VY2_Jansp  28
YPGFVDVKEADWILEQLCQDVP...WKQRTGIREDITYQQPR.LTAWYGEL.......PYTYSRITMEPNPHWH...PVLRTLKNRIEENT...GHTFNSLLCNLYRN.............. ALKB3_HUMAN  93
Sec_2iuw
ITDFLSPDTADQNFNTLSNELE...WRQDQIKMFGKLVAIPR.LQNFMGDPGI.....RYRYSGLTLTASG.WH...PVVKKIKELAEAAS...NTEFNAVLINLYRD.............. Q2BPN4_Ocesp  18
LPAWLDGATADRWLARLLAETP...WERPQVRLYGRLHPVPR.QVAWYGDA.......AYRYSGLTHPPQP.WT...PLLAEIRAALEALV...GRPLNGVLLNHYRD.............. Q4J2C8_Azovi  28
IPGYLNQEQQAALLNEVKSYP....LSRPEVQVYGQTHPIPR.TQVWFGDSGC.....DYRYSGLFVSALP.WP...KYANKLREKLYRDF...KLETNGVLVNRYAD.............. A0IXS6_Shewo  30
LPGWLSTDDAQRWQLLLEHNIS...WEQPLVQVFGKYHRVPR.KTVFLAEQGL.....QYRYSGAIHVGEG.WP...EWFHPLVEQVNHIA...QAQFNGCLLNLYRD.............. Q3AYK8_Synsp  33
LPASLHDDVERAFDDMRSRGE....FTHDVVSAGNKVSTTYV.RRCLLGEDGM.....TYHYQKLRLFAQP.WR...GREAYEVVRRLNE2 0ECEYNVTLINYMETEGESEIELRNEEKF fto_Ostlu  35
LPEALHDDVARAFDSLLREGE....FTHDVLSAGNKVSRTFV.TRTLLGDRGT.....TYHYQKLRLFAQP.WDGE.KRWEYATARRLNE1 8ECEYNVTLINRMDTREESEVALKDEALF fto_Ostta  32
LPSTLHGEFESSFDGMDAGDL....FLYDTVQPGKKRLTRTSVTRTLVGDPGS.....TYKYLGLRLFSHP.WT...DVDKDGNMQSKEQ3 9SAEYNLTLVNKMASTTMKR.DLKNEMAY fto_Thaps  29
LPTELHCRVQAALLTLRRKGC....LLKDLVRVRERDVFTAV.SRALFGEPGH.....TYRYLETRLFALP.WH...SEDSEVKGHNCCD6 7PAKFNVTLLNYMDPAKTSH..LKEEPYY fto_Oryla  56
VPVDLHHTVQNAFLSLLRNGC....LFQDLVRLKGKDIITPV.SRILIGRPGY.....TYKYLNTRLFAVP.WI...NDELNTQYSTRNL6 1MESFNVTLINYMDPQNMSF..LKEEPYF fto_Xenla  57
IPEELHKEVPEAFLTLHKHGC....LFRDVVRIQGKDVLTPV.SRILIGDPGC.....TYKYLNTRLFTVP.WP...VKGCTVKYTEAEI6 0RAAYNVTLLNFMDPQKMPY..LKEEPYF fto_Mouse  57
VSEELHKEVQEAFLTLHKHGC....LFRDLVRIQGKDLLTPV.SRILIGNPGC.....TYKYLNTRLFTVP.WP...VKGSNIKHTEAEI6 3RAAYNVTLLNFMDPQKMPY..LKEEPYF fto_Human  57
PhD_FTOpred
...GAKLSLHQDKDEPDL.RAPIVSVSLGLP................AIFQFGGLKRN.........DPLKRLLLEHGDVVVWGGESRL.FYHGIQPLKAGFHPL.TIDCRYNLTFRQA ALKB_ECOLI 125 212
Sec_2fdi
...GAKLSLHQDKDEQDF.SQPIVSVSLGLA................ATFLFGGLRRS.........DPVLRTELNHGDVVVWGGQARL.RYHGILPLKPGEHPL.TGDVRINLTFRAA Q1H1R8_Metfl 153 240
...GARMGLHRDQDEHDF.AAPIVSVSLGLA................CSFLWGGLTRQ.........SPTRRLALTHGDVLVWGGPSRL.VFHGVAPLKPGQHPL.LGNERWNLTFRMA A0HF04_Comte 126 213
...GARMGLHQDRDEADP.RFPVLSISLGDT................AVFRIGGVNRK.........DPTRSLRLASGDVCRLLGPARL.AFHGVDRILPGSSSLVPGGGRINLTLRRA O05725_Caucr 129 217
...GAKMGMHQDRDEGDF.DMPVVSVSLGDE................ALFRVGGPKRG.........GKTQSVWLKSGDVAVMGGEARL.NFHGIDRIRAGSSTLLPNGGRINLTMRVV Q28VY2_Jansp 127 215
..EKDSVDWHSDDEPSLGRCPIIASLSFGAT................RTFEMRKKPPPEENG.DYTYVERVKIPLDHGTLLIMEGATQADWQHRVPKEYHS......REPRVNLTFRTV ALKB3_HUMAN 184 277
Sec_2iuw
..GQDSMGWHKDDEPELGPEPTIVSVSLGAT................RRFLLRAA.DK..........TQHELLLNSGSLLVMGPELQKHWQHSIPKTRKQ......IGPRINLTFRKI Q2BPN4_Ocesp 110 193
..GRDSMGWHSDDEAELGRDPLIVSLSLGGT................RRFDLRRVGQTR.........IERSLLLEHGSVLVMAGATQHHWQHQVAKTRKP......CAPRLNLTFRQV Q4J2C8_Azovi 118 203
..GRDSMGWHCDDEVEIRSGSDIASVSIGAR................RDFFIRHKVSL..........QKYQIPLNSGDLLIMHWPMQNEWEHSVPKRLKV......MEPRVNFTFRLL A0IXS6_Shewo 121 205
..GDDRMGWHADDEPEIDQTQPIASLSLGST................RDFLFRHRGDQP.........KRAAIPLADGDLLIMHPGCQGHWMHSVPQRRKV......KTMRINLTFRHF Q3AYK8_Synsp 125 210
DLGTTSVSWHSDSSLRENSTVAVYHTYEAPE...............RKDWRVALRALN.......AECEVLCVPLEDKATYYMCGEFNATHHHAVLTGS.........SARYSSTHRVA fto_Ostlu   246
DLGTTSVSWHSDSSLRENSTVAVYSTVDDPE...............RADWSVALRALG.......KQCPALRVPLKDKATYYMCGDFNATHHHAVLTGS.........SARYSSTHRVG fto_Ostta   243
NMGKISVGWHRDSGLKDFSSIAVYQTLKDTATA..............NSWGVAIRAMDGGTGGPLASVPALLVPLPSGSLYYMFDDFNHNHEHAVIAGS........DGVRYSSTHRVA fto_Thaps   268
GMGKMAVGWHHDENLISNSPVAVYNYSYHNDKEMSKGESSEGGTGEKTCWRIGLKVAWD......IHTPGLMVPLESGDCYYMRDNLNSTHQHCVLAGE.........TARFSSTHRVA fto_Oryla   328
GMGKMAVSWHHDENLVEQSTVAVYNYSYQESSNDVNGEDE.....DPTRWHVGLKIAWD......IETPGLLMPLSSGDCYLMLDDLNKTHQHCVIAGC.........QPRFSSTHRVA fto_Xenla   318
GMGKMAVSWHHDENLVDRSAVAVYSYSCEGSEDESEDESSFEGR.DPDTWHVGFKISWD......IETPGLTIPLHQGDCYFMLDDLNATHQHCVLAGS.........QPRFSSTHRVA fto_Mouse   321
GMGKMAVSWHHDENLVDRSAVAVYSYSCEGPEEESEDDSHLEGR.DPDIWHVGFKISWD......IETPGLAIPLHQGDCYFMLDDLNATHQHCVLAGS.........QPRFSSTHRVA fto_Human   324
PhD_FTOpred
118,120
131, 204 133 210 187
His 187
His 131
Leu 118
Asn 120
Asp 133
Arg 210
2OG
Fe
Arg 204BMC Biochemistry 2007, 8:23 http://www.biomedcentral.com/1471-2091/8/23
Page 4 of 6
(page number not for citation purposes)
hood of determining its cellular localization, which could
be verified by mutational analysis.
Conclusion
Here we have provided valuable information about FTO
by indicating its possible catalytic function, and we have
pointed to the amino acids involved in cofactor (Fe) and
co-substrate (2-oxoglutarate) binding in human FTO as
well as in its homologous proteins in other organisms,
which could be used as models for the study of the human
disease. This insight should help to guide experiments to
clarify the mechanisms by which FTO relates to obesity
and to accelerate the discovery of novel molecular thera-
pies for this condition.
Methods
We first performed BLAST sequence similarity searches
[13] using the human FTO protein as query against differ-
ent sequence database resources: NCBI [14], ENSEMBL
[15] and JGI [16]. Multiple sequence alignments of pro-
tein sequences homologous to human FTO were gener-
ated with the program T-Coffee [17] using default
parameters, slightly refined manually and visualized with
the Belvu program (Figure 1. Top) [18].
Profiles of the alignment as global hidden Markov models
(HMMs) were generated using HMMer [19]. Profile-based
sequence searches were performed against the Uniref50
and Uniref90 protein sequence databases [20] using
HMMsearch [21]. We used NAIL [22] to view and analyze
the HMMsearch results, which provided a formatted view
with hyperlinks to related web resources and coloring
related to taxonomic information, thus facilitating the
interpretation of the results.
Fold recognition analyses were performed using profile-
to-profile comparisons of the HMM profile of the FTO
family to profiles generated for each sequence of known
structure with its homologues (HHpred server; [23,24]).
The significance of sequence-to-sequence, profile-to-
sequence, and profile-to-profile matches were evaluated
in terms of an E-value, which is an estimation of the prob-
ability of finding a better match by chance. Secondary
structure predictions were performed using the Predict-
Protein Server [25,26]. AlkB active center illustrations
(Figure 1. Bottom) were generated with Pymol [27].
Abbreviations
2OG (2-oxoglutarate)
AlkB (Alkylated DNA repair protein)
ESTs (Expressed sequence tags)
FGENESH (Find Genes using HMM)
FTO (fat mass and obesity associated)
HIF (Hypoxia-inducible factor)
HMMs (Hidden Markov Models)
JGI (Joint Genome Institute)
Table 1: Additional details for lanes in Figure 1 and FTO close homologous sequences in Figures 1 and 2.
Identifier Obtained from Species Representing
ALKB_ECOLI SwissProt Escherichia coli Alpha-ketoglutarate-dependent dioxygenase AlkB
Sec_2fdi 2D structure
ALKB3_HUMAN SwissProt Homo Sapiens hABH3 (human AlkBHomolog 3)
Sec_2iuw 2D structure
fto_Ostlu gi:145352974 & FGENESH+1 Ostreococcus lucimarinus Homolog to FTO
fto_Ostta gi:116060758 & FGENESH+1 Ostreococcus tauri Homolog to FTO
AACY020075623 AACY020075623 & FGENESH+1 Marine metagenome Homolog to FTO (not shown in Fig. 1)
fto_Thaps JGI database & FGENESH+1 Thalassiosira pseudonana Homolog to FTO
fto_Phatr JGI database & FGENESH+1 Phaeodactylum tricornutum Homolog to FTO (not shown in Fig. 1)
fto_Oryla Ensembl1 Oryzia latipes Homolog to FTO
fto_Xenla Sptrembl: Q68F541 Xenopus laevis Homolog to FTO
fto_Xentr UniRef100: UPI0000509E0B Xenopus tropicalis Homolog to FTO
fto_Bosta UniRef100: A5D798 Bos taurus Homolog to FTO
fto_Canfa JGI database & FGENESH+1 Canis familiaris Homolog to FTO
fto_Ratno UniRef100: Q2A121 Rattus norvegicus Homolog to FTO
fto_Mouse SwissProt: FATSO_MOUSE Mus musculus Homolog to FTO
fto_Human SwissProt: FATSO_HUMAN1 Homo sapiens FTO
PhD_FTOpred 2D Structure2
1Manually assembled ESTs from NCBI [31] and homologous sequences were used in order to produce accurate gene predictions supported by 
homology information.
2Secondary structure prediction using PHD [26].BMC Biochemistry 2007, 8:23 http://www.biomedcentral.com/1471-2091/8/23
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NBCI (National Center for Biotechnology Information)
NLS (Nuclear Localization Signal)
SNPs (Single nucleotide polymorphisms)
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